BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $226,440 | -17.2% | 6,000 | 0.0% | 0.03% | -12.8% |
Q2 2023 | $273,360 | +12.3% | 6,000 | 0.0% | 0.04% | +2.6% |
Q1 2023 | $243,360 | -20.4% | 6,000 | 0.0% | 0.04% | -22.4% |
Q4 2022 | $305,820 | -5.3% | 6,000 | 0.0% | 0.05% | -10.9% |
Q3 2022 | $323,000 | -16.1% | 6,000 | 0.0% | 0.06% | -12.7% |
Q2 2022 | $385,000 | -17.2% | 6,000 | 0.0% | 0.06% | 0.0% |
Q1 2022 | $465,000 | -9.7% | 6,000 | 0.0% | 0.06% | -3.1% |
Q4 2021 | $515,000 | +6.6% | 6,000 | 0.0% | 0.06% | -1.5% |
Q3 2021 | $483,000 | 0.0% | 6,000 | 0.0% | 0.07% | +3.1% |
Q2 2021 | $483,000 | -4.5% | 6,000 | 0.0% | 0.06% | -11.1% |
Q1 2021 | $506,000 | +5.2% | 6,000 | 0.0% | 0.07% | -2.7% |
Q4 2020 | $481,000 | -0.4% | 6,000 | 0.0% | 0.07% | -14.9% |
Q3 2020 | $483,000 | -6.6% | 6,000 | 0.0% | 0.09% | -10.3% |
Q2 2020 | $517,000 | +6.2% | 6,000 | 0.0% | 0.10% | -12.6% |
Q1 2020 | $487,000 | -3.0% | 6,000 | 0.0% | 0.11% | +30.6% |
Q4 2019 | $502,000 | -4.4% | 6,000 | 0.0% | 0.08% | -11.5% |
Q3 2019 | $525,000 | +6.9% | 6,000 | 0.0% | 0.10% | +9.1% |
Q2 2019 | $491,000 | +0.6% | 6,000 | 0.0% | 0.09% | -1.1% |
Q1 2019 | $488,000 | -42.2% | 6,000 | -70.0% | 0.09% | -50.6% |
Q1 2016 | $844,000 | +10.6% | 20,000 | 0.0% | 0.18% | +14.6% |
Q4 2015 | $763,000 | +16.1% | 20,000 | 0.0% | 0.16% | +10.6% |
Q3 2015 | $657,000 | -53.0% | 20,000 | 0.0% | 0.14% | -47.8% |
Q2 2015 | $1,399,000 | +2.1% | 20,000 | 0.0% | 0.27% | +2.6% |
Q1 2015 | $1,370,000 | -6.5% | 20,000 | 0.0% | 0.26% | -7.3% |
Q4 2014 | $1,466,000 | +2.2% | 20,000 | 0.0% | 0.29% | -2.1% |
Q3 2014 | $1,435,000 | -0.8% | 20,000 | 0.0% | 0.29% | +2.1% |
Q2 2014 | $1,446,000 | -1.8% | 20,000 | 0.0% | 0.29% | -5.3% |
Q1 2014 | $1,472,000 | – | 20,000 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |